Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma

ABSTRACT:

SUBMITTER: van Meerten T 

PROVIDER: S-EPMC11236767 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature